Cooper Rodgers, MD
Ophthalmology · Olathe, KSNPI 1972122687
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Alcon at 31.9% of the total. 2025 is the largest year on record at $883, 2.9 times the $308 reported in 2023.
Across 30 payments — averaging $64.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$619
- Biotissue Holdings Inc.$341
- Glaukos Corporation$267
- Sun Pharmaceutical Industries Inc.$142
- Rayner Intraocular Lenses Limited$126
- Harrow Eye, LLC$124
- plus $321 from 8 others
What the payments were for
- Food & beverage$1,940100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 10 | $619 |
| Biotissue Holdings Inc. | 5 | $341 |
| Glaukos Corporation | 2 | $267 |
| Sun Pharmaceutical Industries Inc. | 2 | $142 |
| Rayner Intraocular Lenses Limited | 1 | $126 |
| Harrow Eye, LLC | 1 | $124 |
| NEW World Medical,inc. | 1 | $90 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $82 |
| AbbVie | 2 | $47 |
| Dompe US, Inc. | 1 | $24 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Oyster Point Pharma, Inc. | 1 | $21 |
| Rxsight Inc | 1 | $18 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KXL System$153
- AcrySof IQ PanOptix UV IOL$136
- Centurion$133
- Clareon$127
- RayOne EMV$126
- RayOne Spheric$126
- RayOne Aspheric$126
- Flarex$124
- IHEEZO$124
- Verkazia$124
- Tobradex ST$124
- Natacyn$124
- CEQUA$119
- CE-marked KXLA system$114
How this compares
$1,940 in reported general payments places this provider in the 55th percentile of 135 ophthalmology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate | 12 | $891 |
| Prednisolone Acetate | 15 | $395 |
| Latanoprost | 49 | $390 |
| Ketorolac Tromethamine | 18 | $297 |
| Dorzolamide Hcl | 11 | $169 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 11 | $135 |
| ErythromycinErythromycin Base | 13 | $120 |
| Azithromycin | 11 | $51 |
| Timolol Maleate | 14 | $45 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Olathe
- Jeff WongskhaluangOlathe$42K
- Brian HeinigerOlathe$4K
- Milton GrinOlathe$3K
- Daniel DurrieOverland Park$974K
- John DoaneLeawood$496K
- John HunkelerOverland Park$218K
- Christopher PoleOverland Park$129K
- Blake CooperLenexa$100K
- Miranda BisharaPrairie Village$45K
- Michael EllisLenexa$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.